NBC News - A new gene therapy to treat progressive blindness will cost $850,000, the company that makes it said Wednesday.
But the company has laid groundwork for innovative ways to pay for the drug though deals with an insurance company, a pharmacy benefit manager and negotiating with the federal government. The company hopes its $425,000-per-eye treatment may eventually lead to new ways to pay for extremely expensive new therapies. Luxturna was just approved by the Food and Drug Administration last month after a dramatic hearing where teenagers spoke of seeing the stars...>>>
Nessun commento:
Posta un commento